Dr. Dunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
# Wescoe
Kansas City, KS 66160Phone+1 507-284-2511Fax+1 913-588-3975
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2009 - 2010
- University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2006 - 2009
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003
Certifications & Licensure
- CA State Medical License 2005 - Present
- KS State Medical License 2010 - 2025
- MO State Medical License 2021 - 2025
- MN State Medical License 2009 - 2011
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 374 citationsMELD accurately predicts mortality in patients with alcoholic hepatitisWinston Dunn, Laith H. Jamil, Larry S. Brown, Russell H. Wiesner, W. Ray Kim
Hepatology. 2005-02-01 - 51 citationsIdentification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.Juan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, Francisco Idalsoaga, Eduardo Fuentes-López
Journal of Hepatology. 2021-11-01 - 153 citationsPredictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study.Donghee Kim, Nia Adeniji, Nyann Latt, Sonal Kumar, Patricia P. Bloom
Clinical Gastroenterology and Hepatology. 2021-07-01
Press Mentions
- Gene Predicts Recovery from Decompensated HCV CirrhosisApril 10th, 2019
- Study: Genetic Markers May Predict Which HCV, Cirrhosis Patients Improve with TreatmentMay 6th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: